Health Disparities in Cardiometabolic Disease Seen Within Racial Subgroups

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Jan. 25, 2024 -- Health disparities are seen in the prevalence of cardiometabolic diseases by disaggregated racial and ethnic subgroups, according to research published in the Jan. 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Alain K. Koyama, Sc.D., from the CDC in Atlanta, and colleagues describe the prevalence of diagnosed cardiometabolic diseases among U.S. adults by disaggregated racial and ethnic subgroups using data from 3,970,904 respondents to the Behavioral Risk Factor Surveillance System from 2013 to 2021. The prevalence of diabetes, myocardial infarction, angina or coronary heart disease, and stroke was stratified by race and ethnicity.

The mean respondent age was 47.5 years, and more than half (51.4 percent) of the respondents were women. The researchers found that among disaggregated race and ethnicity subgroups, there was considerable variation seen in the prevalence of cardiometabolic diseases. Within the aggregated non-Hispanic Asian category, the prevalence of diabetes was 11.5 percent and ranged from 6.3 to 15.2 percent in the Vietnamese and Filipino subgroups, respectively. For the aggregated Hispanic or Latino category, the prevalence of angina or coronary heart disease was 3.8 percent and varied from 3.1 to 6.3 percent in the Cuban and Puerto Rican subgroups, respectively.

"Findings from this study illustrate pronounced differences in cardiometabolic disease prevalence among racial and ethnic subgroups, with the largest variation occurring in diabetes prevalence," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-26 06:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords